Stay updated with breaking news from Rivermount Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neurava Inc.'s owners are developing a device aimed at mitigating the risk of sudden unexpected death in epilepsy, a mysterious condition that takes an estimated 3,000 lives a year in the United States.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Neurava announced that it has completed and oversubscribed its Series Seed round, raising $2.26 million. Neurava is developing novel and...
Neurava announced today that it completed an oversubscribed seed financing round worth proceeds of $2.26 million.